KYNB:BMV
Kyntra Bio Inc
MX$118.20
0.00%
(0.00) 1D
Jun 3, 9:41:27 AM GMT-6 · MXN
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KYNB...
Mkt. cap
28.86M
Avg. vol.
12.00
Volume
0.00
52-wk high
MX$166.01
52-wk low
MX$118.20
No. of employees
34
Mkt. cap
28.86M
Avg. vol.
12.00
Volume
0.00
52-wk high
MX$166.01
52-wk low
MX$118.20
No. of employees
34
News stories
From sources across the web
Profile
Kyntra Bio, Inc. is a biopharmaceutical company headquartered in San Francisco, California. Once regarded as a promising developer of innovative therapies for anemia and fibrotic diseases, with a market capitalization of roughly $4 billion in 2018–19, the company's value collapsed following late-stage trial failures, regulatory setbacks, and a data manipulation scandal. By 2026, Kyntra was mainly reduced to a single early-stage oncology drug candidate.
On January 8, 2026, FibroGen changed its name to Kyntra Bio and ticker symbol to KYNB. Wikipedia
About Kyntra Bio Inc
CEO-
Employees34
FoundedJan 1, 1993
HeadquartersSan Francisco, California, United States
SectorBiotechnology
Websitefibrogen.com
AI content may include mistakes. Learn more